CAPR - Capricor Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-12    (Delayed quote data   2025-01-06)
Last
 15.00		 Change
 ⇓ -0.61   (-3.91%)		 Volume
  826,932
Open
 15.74		 High
 15.79		 Low
 14.97
8EMA (Daily)
 14.55		 40EMA (Daily)
 15.26		 50EMA (Daily)
 15.21		 STO (Daily)
 70.806		 MACD Hist (Daily)
 0.550
8EMA (Weekly)
 15.252		 40EMA (Weekly)
 11.30		 50EMA (Weekly)
 10.40		 STO (Weekly)
 41.768		 MACD Hist (Weekly)
 -1.114
Company Profile
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com